Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
S2M
Linköping, Sweden
- Ownership
- Private
- Development stage
- Other
01
Overview
S2Medical has advanced wound healing products (notably Epiprotect and IvaQ) and a novel antimicrobial peptide platform (ADMERCIN) for infection control. Epiprotect is commercialized (ownership now with Abena), while IvaQ is market-ready (CE-marked). Several products are already launched or ready for commercialization in Europe
- Therapeutic areas
- Infectious DiseasesDermatologyOther
- Modalities
- Advanced wound dressing (biomaterial)Negative pressure wound therapy deviceAntimicrobial peptide therapySkin substitute
- Industry
- Biotech
02
Partnerships
ABENA (Epiprotect and Eiratex product line now with ABENA, global distribution)LYKO (distribution for Eyracure hair repair technology)
Beyond the preview
Go deeper on S2M.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on S2M.